Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2424 | 2180 | 42.1 | 89% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | S100A4 | Author keyword | 174 | 68% | 7% | 153 |
2 | S100A9 | Author keyword | 129 | 75% | 4% | 94 |
3 | S100A2 | Author keyword | 72 | 91% | 1% | 30 |
4 | S100A8 | Author keyword | 67 | 63% | 3% | 67 |
5 | S100 PROTEINS | Author keyword | 64 | 52% | 4% | 86 |
6 | S100P | Author keyword | 53 | 67% | 2% | 48 |
7 | S100A6 | Author keyword | 44 | 67% | 2% | 40 |
8 | S100A7 | Author keyword | 39 | 74% | 1% | 29 |
9 | S100A1 | Author keyword | 39 | 64% | 2% | 38 |
10 | CALPROTECTIN | Author keyword | 36 | 29% | 5% | 105 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | S100A4 | 174 | 68% | 7% | 153 | Search S100A4 | Search S100A4 |
2 | S100A9 | 129 | 75% | 4% | 94 | Search S100A9 | Search S100A9 |
3 | S100A2 | 72 | 91% | 1% | 30 | Search S100A2 | Search S100A2 |
4 | S100A8 | 67 | 63% | 3% | 67 | Search S100A8 | Search S100A8 |
5 | S100 PROTEINS | 64 | 52% | 4% | 86 | Search S100+PROTEINS | Search S100+PROTEINS |
6 | S100P | 53 | 67% | 2% | 48 | Search S100P | Search S100P |
7 | S100A6 | 44 | 67% | 2% | 40 | Search S100A6 | Search S100A6 |
8 | S100A7 | 39 | 74% | 1% | 29 | Search S100A7 | Search S100A7 |
9 | S100A1 | 39 | 64% | 2% | 38 | Search S100A1 | Search S100A1 |
10 | CALPROTECTIN | 36 | 29% | 5% | 105 | Search CALPROTECTIN | Search CALPROTECTIN |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MRP14 | 180 | 77% | 6% | 123 |
2 | P9KA | 176 | 96% | 2% | 53 |
3 | CYSTIC FIBROSIS ANTIGEN | 117 | 93% | 2% | 43 |
4 | MRP 14 | 92 | 92% | 2% | 36 |
5 | CALCYCLIN | 86 | 67% | 4% | 78 |
6 | CALCIUM BINDING PROTEINS | 83 | 18% | 20% | 429 |
7 | CP 10 | 69 | 96% | 1% | 22 |
8 | LEUKOCYTE L1 PROTEIN | 62 | 90% | 1% | 27 |
9 | METASTASIS ASSOCIATED PROTEIN | 58 | 86% | 1% | 30 |
10 | PEL98 PROTEIN | 48 | 100% | 1% | 17 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Functions of S100 Proteins | 2013 | 91 | 389 | 56% |
S100A4 and Metastasis A Small Actor Playing Many Roles | 2010 | 126 | 56 | 89% |
S100 proteins in cancer | 2015 | 3 | 178 | 78% |
The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer | 2009 | 192 | 112 | 72% |
S100 protein family in human cancer | 2014 | 15 | 278 | 74% |
A review of the S100 proteins in cancer | 2008 | 199 | 120 | 81% |
S100A4 calcium-binding protein is key player in tumor progression and metastasis: preclinical and clinical evidence | 2012 | 45 | 75 | 91% |
Inflammation-associated S100 proteins: new mechanisms that regulate function | 2011 | 72 | 204 | 76% |
S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles | 2001 | 857 | 264 | 44% |
The S100 family of EF-hand calcium-binding proteins: Functions and pathology | 1996 | 829 | 28 | 43% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EXPT DERMATOL | 17 | 23% | 3.1% | 67 |
2 | CARDIAC STEM CELL GENE THER Y | 17 | 75% | 0.6% | 12 |
3 | CLIN CHEM BIOCHEM | 15 | 16% | 4.0% | 87 |
4 | CYTOKINE UNIT | 13 | 61% | 0.6% | 14 |
5 | MCLAUGHLIN MACROMOL STRUCT IL | 9 | 67% | 0.4% | 8 |
6 | CANC POLIO FUND S | 5 | 34% | 0.6% | 12 |
7 | MED UNIV KLIN POLIKLIN 3 | 4 | 75% | 0.1% | 3 |
8 | MOL TRANSLAT CARDIOL | 4 | 29% | 0.5% | 11 |
9 | CANC TISSUE BANK | 3 | 32% | 0.4% | 9 |
10 | CARDIOL MEDKEENAN | 3 | 60% | 0.1% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000208762 | MYXOID TISSUE//S 100A//S100 ALPHA PROTEIN |
2 | 0.0000114682 | RAGE//RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS//SRAGE |
3 | 0.0000067913 | S 100B//S 100B PROTEIN//NEURON SPECIFIC ENOLASE |
4 | 0.0000067010 | HUMAN BRONCHOALVEOLAR LAVAGE FLUID PROTEINS//CALCYPHOSINE//FUNCT PROTE SECT |
5 | 0.0000063992 | HIPK2//CACYBP SIP//CACYBP |
6 | 0.0000060575 | FECAL CALPROTECTIN//CALPROTECTIN//FECAL ALPHA 1 ANTITRYPSIN |
7 | 0.0000050174 | ONCOMODULIN//SARCOPLASMIC CALCIUM BINDING PROTEIN//EF HAND |
8 | 0.0000043645 | CIBER BBN SALUD CARLOS 3//RIER RED INFLAMAC ENFERMEDADES REUMAT//PROTEORED ISCIII PROTE GRP |
9 | 0.0000041001 | MIA//CIRCULATING MELANOMA CELLS//MELANOMA INHIBITORY ACTIVITY |
10 | 0.0000039438 | INVOLUCRIN//SMALL PROLINE RICH PROTEINS//SMALL PROLINE RICH PROTEIN |